Healthcare -
Biotechnology - NASDAQ - US
$ 8.01
1.91 %
$ 1.18 B
Market Cap
-5.98
P/E
ADPT - COST OF REVENUE
Cost of Revenue ADPT - Adaptive Biotechnologies Corporation
75.6 M
LAST VALUE
23.79%
2 YEAR CAGR
30.89%
5 YEAR CAGR
0.00%
10 YEAR CAGR